- Home
- IBG vs IMCC Comparison
IBG vs IMCC Comparison
Compare IBG & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- IMCC
- Stock Information
- Founded
- IBG 2018
- IMCC 1980
- Country
- IBG Australia
- IMCC Israel
- Employees
- IBG N/A
- IMCC N/A
- Industry
- IBG Beverages (Production/Distribution)
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- IBG Consumer Staples
- IMCC Health Care
- Exchange
- IBG Nasdaq
- IMCC Nasdaq
- Market Cap
- IBG 6.0M
- IMCC 5.3M
- IPO Year
- IBG 2024
- IMCC N/A
- Fundamental
- Price
- IBG $0.55
- IMCC $2.65
- Analyst Decision
- IBG Strong Buy
- IMCC
- Analyst Count
- IBG 1
- IMCC 0
- Target Price
- IBG N/A
- IMCC N/A
- AVG Volume (30 Days)
- IBG 115.7K
- IMCC 465.6K
- Earning Date
- IBG 07-11-2025
- IMCC 08-13-2025
- Dividend Yield
- IBG N/A
- IMCC N/A
- EPS Growth
- IBG N/A
- IMCC N/A
- EPS
- IBG N/A
- IMCC N/A
- Revenue
- IBG $2,931,243.00
- IMCC $37,894,737.00
- Revenue This Year
- IBG N/A
- IMCC $47.12
- Revenue Next Year
- IBG N/A
- IMCC $12.83
- P/E Ratio
- IBG N/A
- IMCC N/A
- Revenue Growth
- IBG N/A
- IMCC 12.68
- 52 Week Low
- IBG $0.44
- IMCC $1.29
- 52 Week High
- IBG $3.35
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- IBG N/A
- IMCC 50.26
- Support Level
- IBG N/A
- IMCC $2.67
- Resistance Level
- IBG N/A
- IMCC $3.35
- Average True Range (ATR)
- IBG 0.00
- IMCC 0.40
- MACD
- IBG 0.00
- IMCC -0.05
- Stochastic Oscillator
- IBG 0.00
- IMCC 33.94
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.